Answer
No. It does not correct the inherited enzyme defect; it reduces liver production of harmful haem precursors by silencing ALAS1 messenger RNA.
Sources for this answer
- Givlaari — Current selected SmPCemc · Summary of Product Characteristics
- NHSNHS · NHS medicine guidance
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.